Implantica AG (FRA:8IM1)
Germany · Delayed Price · Currency is EUR 5.29
+0.42 (8.74%)
Last updated: Aug 26, 2026, 9:12 AM CET
Implantica AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.47 | 2.07 | 1.94 | 1.41 | 0.84 | 0.39 | |
Revenue Growth | 25.71% | 7.08% | 37.50% | 67.22% | 117.57% | 154.60% |
Cost of Revenue | 2.65 | 2.62 | 3.05 | 1.32 | 1.26 | 1.25 |
Gross Profit | -0.18 | -0.55 | -1.12 | 0.09 | -0.42 | -0.87 |
Selling, General & Admin | 12.14 | 12.62 | 12.16 | 14.95 | 12.22 | 5.93 |
Research & Development | 7.56 | 7.35 | 12.19 | 7.02 | 5.81 | 6.34 |
Other Operating Expenses | - | - | - | -0.03 | - | - |
Operating Expenses | 19.7 | 19.97 | 24.35 | 21.93 | 18.03 | 12.27 |
Operating Income | -19.88 | -20.52 | -25.47 | -21.84 | -18.45 | -13.14 |
Interest Expense | -0.48 | -0.01 | -0.05 | -0.03 | -0.34 | -0.64 |
Interest & Investment Income | 0.7 | 0.93 | 0.79 | 0.68 | 0.04 | - |
Currency Exchange Gain (Loss) | -0.16 | -0.16 | 1.11 | -3.19 | -2.63 | -1.65 |
Other Non Operating Income (Expenses) | -0.02 | -0.02 | -0.02 | -0.05 | -0.03 | -0.02 |
Pretax Income | -19.84 | -19.78 | -23.64 | -24.43 | -21.4 | -15.45 |
Income Tax Expense | 0.03 | 0.03 | 0.05 | 0.07 | -0.04 | 0.02 |
Earnings From Continuing Operations | -19.87 | -19.82 | -23.69 | -24.5 | -21.36 | -15.47 |
Minority Interest in Earnings | 0.15 | 0.19 | 0.35 | 0.76 | 0.54 | 0.11 |
Net Income | -19.72 | -19.63 | -23.33 | -23.74 | -20.82 | -15.36 |
Net Income to Common | -19.72 | -19.63 | -23.33 | -23.74 | -20.82 | -15.36 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 283 | 283 | 283 | 283 | 283 | 282 |
Shares Outstanding (Diluted) | 283 | 283 | 283 | 283 | 283 | 282 |
Shares Change | 0.06% | 0.04% | 0.01% | -0.01% | 0.56% | 6.82% |
EPS (Basic) | -0.07 | -0.07 | -0.08 | -0.08 | -0.07 | -0.05 |
EPS (Diluted) | -0.07 | -0.07 | -0.08 | -0.08 | -0.07 | -0.05 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -15.69 | -16.63 | -22.79 | -20 | -16.02 | -11.64 |
Free Cash Flow Per Share | -0.06 | -0.06 | -0.08 | -0.07 | -0.06 | -0.04 |
Gross Margin | -7.45% | -26.48% | -57.65% | 6.46% | -50.00% | -224.03% |
Operating Margin | -805.31% | -990.01% | -1315.39% | -1551.14% | -2190.86% | -3395.61% |
Profit Margin | -798.66% | -946.74% | -1205.22% | -1686.36% | -2473.16% | -3969.25% |
Free Cash Flow Margin | -635.48% | -802.03% | -1177.22% | -1420.10% | -1902.49% | -3006.72% |
EBITDA | -19.9 | -20.44 | -25.39 | -21.77 | -18.39 | -13.1 |
D&A For EBITDA | -0.01 | 0.08 | 0.07 | 0.07 | 0.06 | 0.04 |
EBIT | -19.88 | -20.52 | -25.47 | -21.84 | -18.45 | -13.14 |